Robyn T. Domsic
Elite in Scleroderma

Dr. Robyn T. Domsic

Rheumatology
UPMC
UPMC St. Margaret Rheumatology
200 Delafield Road, St Margaret Medical Arts Bldg, Suite 4040, 
Pittsburgh, PA 
On Staff At
Accepting New Patients
Offers Telehealth

Elite in Scleroderma
UPMC
UPMC St. Margaret Rheumatology
200 Delafield Road, St Margaret Medical Arts Bldg, Suite 4040, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robyn Domsic, MD, specializes in rheumatology and is certified by the American Board of Internal Medicine. She practices at University of Pittsburgh Physicians, Department of Medicine, Division of Rheumatology and is affiliated with UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Presbyterian, and UPMC Mercy. She completed her medical degree at University of Iowa College of Medicine.

Dr. Domsic is rated as an Elite provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.

Her clinical research consists of co-authoring 106 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 92 articles and participated in 7 clinical trials in the study of Scleroderma.

Graduate Institution
University Of Iowa College Of Medicine
Residency
Duke University School of Medicine
Specialties
Rheumatology
Licenses
Internal Medicine in PA
Board Certifications
American Board Of Internal Medicine
Fellowships
University of Pittsburgh School of Medicine
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Upmc St Margaret
Upmc Passavant
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

UPMC St. Margaret Rheumatology
200 Delafield Road, St Margaret Medical Arts Bldg, Suite 4040, Pittsburgh, PA 15215
Call: 412-784-1466
Other Locations
UPMC Arthritis and Autoimmunity Center
3601 5th Avenue, Suite 2B, Pittsburgh, PA 15213
Call: 412-438-2964

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
Enrollment Status: Completed
Publish Date: December 15, 2023
Intervention Type: Drug
Study Drugs: Pirfenidone, Mycophenolate Mofetil
Study Phase: Phase 2
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 18, 2022
Intervention Type: Drug
Study Drug: JBT-101
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
The Effect of Atorvastatin on Microvascular Endothelial Function and Raynaud in Early Diffuse Systemic Sclerosis
The Effect of Atorvastatin on Microvascular Endothelial Function and Raynaud in Early Diffuse Systemic Sclerosis
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Enrollment Status: Completed
Publish Date: September 24, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

106 Total Publications

Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience.
Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience.
Journal: The European respiratory journal
Published: July 22, 2025
View All 106 Publications
Similar Doctors
Robert A. Lafyatis
Elite in Scleroderma
Dr. Robert A. Lafyatis
Rheumatology
Elite in Scleroderma
Dr. Robert A. Lafyatis
Rheumatology

UPMC Arthritis And Autoimmunity Center

3601 5th Avenue, Suite 2B, 
Pittsburgh, PA 
 (0.1 miles away)
412-530-4505
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Lafyatis, MD, is a rheumatologist and is certified in rheumatology by the American Board of Internal Medicine. He is  the Thomas Medsger Professor of Medicine at the University of Pittsburgh School of Medicine. He received his medical degree from University of Cincinnati and completed his residency at Wake Forest School of Medicine, followed by his fellowship at National Institutes of Health. Dr. Lafyatis’s clinical interests include systemic sclerosis (scleroderma) and its complications in the skin and lungs. His research interests include understanding the underlying cause of scleroderma and finding new treatments. Dr. Lafyatis directs the University of Pittsburgh/University of Pittsburgh Medical Center Scleroderma Center and the National Institutes of Health, Center for Scleroderma Research Translation.  He has over 200 peer-reviewed publications and co-authors the Textbook of Rheumatology chapter on Scleroderma Pathogenesis. Dr. Lafyatis is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Pulmonary Fibrosis, Scleroma, and Pancreaticoduodenectomy.

Amr H. Sawalha
Advanced in Scleroderma
Dr. Amr H. Sawalha
Rheumatology
Advanced in Scleroderma
Dr. Amr H. Sawalha
Rheumatology

UPMC Lupus Center, Oakland, Part Of UPMC Magee-Womens Hospital

580 South Aiken Avenue, Suite 430, 
Pittsburgh, PA 
 (1.4 miles away)
412-586-3550
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amr Sawalha, MD, specializes in rheumatology and is board-certified by the American Board of Internal Medicine. He practices at UPMC Lupus Center of Excellence and is affiliated with UPMC Children's Hospital of Pittsburgh, UPMC Presbyterian, and UPMC Magee-Womens Hospital. Dr. Sawalha received his medical degree from Jordan University of Science and Technology and completed his residency at the University of Oklahoma Health Sciences Center, followed by a fellowship at the University of Michigan Hospital. Dr. Sawalha is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Behcet Disease, Systemic Lupus Erythematosus (SLE), Takayasu Arteritis, and Vasculitis.

Dana P. Ascherman
Advanced in Scleroderma
Dr. Dana P. Ascherman
Rheumatology
Advanced in Scleroderma
Dr. Dana P. Ascherman
Rheumatology

University Of Pittsburgh Physicians

3471 5th Ave, 
Pittsburgh, PA 
 (0.4 miles away)
412-232-7853
Languages Spoken:
English
See accepted insurances

Dana Ascherman is a Rheumatologist in Pittsburgh, Pennsylvania. Dr. Ascherman is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Myositis, Rheumatoid Lung Disease, Dermatomyositis, and Polymyositis.

VIEW MORE SCLERODERMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Domsic's expertise for a condition
ConditionClose
  • Elite
  • Raynaud Phenomenon
    Dr. Domsic is
    Elite
    . Learn about Raynaud Phenomenon.
    See more Raynaud Phenomenon experts
  • Scleroderma
    Dr. Domsic is
    Elite
    . Learn about Scleroderma.
    See more Scleroderma experts
  • Systemic Sclerosis (SSc)
    Dr. Domsic is
    Elite
    . Learn about Systemic Sclerosis (SSc).
    See more Systemic Sclerosis (SSc) experts
  • Distinguished
  • Scleroma
    Dr. Domsic is
    Distinguished
    . Learn about Scleroma.
    See more Scleroma experts
  • Advanced
  • Eosinophilic Fasciitis
    Dr. Domsic is
    Advanced
    . Learn about Eosinophilic Fasciitis.
    See more Eosinophilic Fasciitis experts
  • Localized Scleroderma
    Dr. Domsic is
    Advanced
    . Learn about Localized Scleroderma.
    See more Localized Scleroderma experts
  • Mixed Connective Tissue Disease
    Dr. Domsic is
    Advanced
    . Learn about Mixed Connective Tissue Disease.
    See more Mixed Connective Tissue Disease experts
  • Pulmonary Fibrosis
    Dr. Domsic is
    Advanced
    . Learn about Pulmonary Fibrosis.
    See more Pulmonary Fibrosis experts
  • Experienced
  • Arthritis
    Dr. Domsic is
    Experienced
    . Learn about Arthritis.
    See more Arthritis experts
  • MASS Phenotype
    Dr. Domsic is
    Experienced
    . Learn about MASS Phenotype.
    See more MASS Phenotype experts
  • Myositis
    Dr. Domsic is
    Experienced
    . Learn about Myositis.
    See more Myositis experts
  • Polymyalgia Rheumatica
    Dr. Domsic is
    Experienced
    . Learn about Polymyalgia Rheumatica.
    See more Polymyalgia Rheumatica experts
  • Rheumatoid Arthritis (RA)
    Dr. Domsic is
    Experienced
    . Learn about Rheumatoid Arthritis (RA).
    See more Rheumatoid Arthritis (RA) experts
  • Rhizomelic Pseudopolyarthritis
    Dr. Domsic is
    Experienced
    . Learn about Rhizomelic Pseudopolyarthritis.
    See more Rhizomelic Pseudopolyarthritis experts
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

            By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.